1.
Oh IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006;443:709–12.Google Scholar
2.
Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, Kern W, Hillhouse EW, Lehnert H, Tan BK, Randeva HS. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010;151:3169–80.Web of ScienceGoogle Scholar
3.
Stengel A, Goebel M, Wang L, Tache Y. Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric x/a-like cells: role as regulators of food intake and body weight. Peptides 2010;31:357–69.PubMedCrossrefGoogle Scholar
4.
Nakata M, Manaka K, Yamamoto S, Mori M, Yada T. Nesfatin-1 enhances glucose-induced insulin secretion by promoting ca(2+) influx through l-type channels in mouse islet beta-cells. Endocr J 2011;58:305–13.Web of ScienceCrossrefPubMedGoogle Scholar
5.
Foo KS, Brauner H, Ostenson CG, Broberger C. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 2010;204:255–63.Web of ScienceGoogle Scholar
6.
Aydin S. Multi-functional peptide hormone nucb2/nesfatin-1. Endocrine 2013;44:312–25.CrossrefWeb of ScienceGoogle Scholar
7.
Shimizu H, Oh IS, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009;150:662–71.Web of ScienceGoogle Scholar
8.
Wernecke K, Lamprecht I, Johren O, Lehnert H, Schulz C. Nesfatin-1 increases energy expenditure and reduces food intake in rats. Obesity (Silver Spring) 2014;22:1662–8.CrossrefWeb of ScienceGoogle Scholar
9.
Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh IS, Ariyama Y, Takahashi H, Okada S, Hashimoto K, Satoh T, Kojima M, Mori M. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 2010;73:484–90.Web of ScienceGoogle Scholar
10.
Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010;159:72–7.Web of ScienceGoogle Scholar
11.
Gonzalez R, Perry RL, Gao X, Gaidhu MP, Tsushima RG, Ceddia RB, Unniappan S. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011;152:3628–37.Google Scholar
12.
Su Y, Zhang J, Tang Y, Bi F, Liu JN. The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 2010;391:1039–42.Web of ScienceGoogle Scholar
13.
Zhang Z, Li L, Yang M, Liu H, Boden G, Yang G. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2012;120:91–5.PubMedWeb of ScienceGoogle Scholar
14.
Yang M, Zhang Z, Wang C, Li K, Li S, Boden G, Li L, Yang G. Nesfatin-1 action in the brain increases insulin sensitivity through akt/ampk/torc2 pathway in diet-induced insulin resistance. Diabetes 2012;61:1959–68.Google Scholar
15.
Shimizu H, Mori M. Nesfatin-1: its role in the diagnosis and treatment of obesity and some psychiatric disorders. Methods Mol Biol 2013;963:327–38.Google Scholar
16.
Scotece M, Conde J, Abella V, Lopez V, Lago F, Pino J, Gómez-Reino JJ, Gualillo O. Nucb2/nesfatin-1: a new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study. J Orthop Res 2014;32:653–60.Web of ScienceCrossrefGoogle Scholar
17.
Ghanbari-Niaki A, Kraemer RR, Soltani R. Plasma nesfatin-1 and glucoregulatory hormone responses to two different anaerobic exercise sessions. Eur J Appl Physiol 2010;110:863–8.Google Scholar
18.
Chaolu H, Asakawa A, Ushikai M, Li YX, Cheng KC, Li JB, Zoshiki T, Terashi M, Tanaka C, Atsuchi K, Sakoguchi T, Tsai M, Amitani H, Horiuchi M, Takeuchi T, Inui A. Effect of exercise and high-fat diet on plasma adiponectin and nesfatin levels in mice. Exp Ther Med 2011;2:369–73.Web of SciencePubMedGoogle Scholar
19.
Haghshenas R, Jafari M, Ravasi A, Kordi M, Gilani N, Shariatzadeh M, Hedayati M, Rahimi M. The effect of eight weeks endurance training and high-fat diet on appetite-regulating hormones in rat plasma. Iran J Basic Med Sci 2014;17:237–43.Google Scholar
20.
Earnest CP. Exercise interval training: an improved stimulus for improving the physiology of pre-diabetes. Med Hypotheses 2008;71:752–61.Web of ScienceGoogle Scholar
21.
Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al-Share QY, Skogvoll E, Slørdahl SA, Kemi OJ, Najjar SM, Wisløff U. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008;118:346–54.Web of SciencePubMedCrossrefGoogle Scholar
22.
Whyte LJ, Gill JM, Cathcart AJ. Effect of 2 weeks of sprint interval training on health-related outcomes in sedentary overweight/obese men. Metabolism 2010;59:1421–8.PubMedWeb of ScienceCrossrefGoogle Scholar
23.
Barker AR, Day J, Smith A, Bond B, Williams CA. The influence of 2 weeks of low-volume high-intensity interval training on health outcomes in adolescent boys. J Sports Sci 2014;32:757–65.CrossrefPubMedGoogle Scholar
24.
Boutcher SH. High-intensity intermittent exercise and fat loss. J Obes 2011;2011:868305.PubMedGoogle Scholar
25.
Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. American college of sports medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009;41:459–71.PubMedCrossrefWeb of ScienceGoogle Scholar
26.
Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjaerpe T. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007;115:3086–94.Web of ScienceGoogle Scholar
27.
Helgerud J, Hoydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, Simonsen T, Helgesen C, Hjorth N, Bach R, Hoff J. Aerobic high-intensity intervals improve vo2max more than moderate training. Med Sci Sports Exerc 2007;39:665–71.Web of ScienceCrossrefGoogle Scholar
28.
Zwetsloot KA, John CS, Lawrence MM, Battista RA, Shanely RA. High-intensity interval training induces a modest systemic inflammatory response in active, young men. J Inflamm Res 2014;7:9–17.PubMedCrossrefGoogle Scholar
29.
Hazell TJ, Olver TD, Hamilton CD, Lemon PW. Two minutes of sprint-interval exercise elicits 24-hr oxygen consumption similar to that of 30 min of continuous endurance exercise. Int J Sport Nutr Exerc Metab 2012;22:276–83.Google Scholar
30.
Huang H, Iida KT, Sone H, Yokoo T, Yamada N, Ajisaka R. The effect of exercise training on adiponectin receptor expression in kkay obese/diabetic mice. J Endocrinol 2006;189:643–53.Google Scholar
31.
Moghadasi M, Mohebbi H, Rahmani-Nia F, Hassan-Nia S, Noroozi H, Pirooznia N. High-intensity endurance training improves adiponectin mrna and plasma concentrations. Eur J Appl Physiol 2012;112:1207–14.Web of ScienceCrossrefPubMedGoogle Scholar
32.
Cha SH, Lane MD. Central lactate metabolism suppresses food intake via the hypothalamic amp kinase/malonyl-coa signaling pathway. Biochem Biophys Res Commun 2009;386:212–6.Web of ScienceGoogle Scholar
33.
Nikseresht M, Sadeghifard N, Agha-Alinejad H, Ebrahim K. Inflammatory markers and adipocytokine responses to exercise training and detraining in men who are obese. J Strength Cond Res 2014;28:3399–410.CrossrefPubMedWeb of ScienceGoogle Scholar
34.
Croft L, Bartlett JD, MacLaren DP, Reilly T, Evans L, Mattey DL, Nixon NB, Drust B, Morton JP. High-intensity interval training attenuates the exercise-induced increase in plasma il-6 in response to acute exercise. Appl Physiol Nutr Metab 2009;34:1098–107.PubMedWeb of ScienceGoogle Scholar
35.
Reihmane D, Dela F. Interleukin-6: possible biological roles during exercise. Eur J Sport Sci 2014;14:242–50.Web of ScienceCrossrefPubMedGoogle Scholar
36.
Tonoli C, Heyman E, Roelands B, Buyse L, Cheung SS, Berthoin S, Meeusen R. Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis. Sports Med 2012;42:1059–80.PubMedCrossrefGoogle Scholar
37.
Ahmadizad S, Ghorbani S, Ghasemikaram M, Bahmanzadeh M. Effects of short-term nonperiodized, linear periodized and daily undulating periodized resistance training on plasma adiponectin, leptin and insulin resistance. Clinical biochemistry 2014;47:417–22.Web of ScienceCrossrefPubMedGoogle Scholar
38.
Ogiso K, Asakawa A, Amitani H, Nakahara T, Ushikai M, Haruta I, Koyama K, Amitani M, Harada T, Yasuhara D, Inui A. Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides 2011;32:150–3.PubMedWeb of ScienceCrossrefGoogle Scholar
39.
Aslan M, Celik O, Celik N, Turkcuoglu I, Yilmaz E, Karaer A, Simsek Y, Celik E, Aydin S. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 2012;41: 424–9.CrossrefPubMedGoogle Scholar
40.
Bajpeyi S, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Hickner RC, Kraus WE, Houmard JA. Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation. J Appl Physiol (1985) 2009;106:1079–85.Web of ScienceGoogle Scholar
Comments (0)